glp 1 and gip dual agonist GIPR/GLP-1R therapies for diabetes weight loss—chemistry, physiology, and clinical applications The Effects of Dual GLP-1/GIP
Description
For example, prenatal multivitamins are usually prescribed by healthcare providers to meet the higher nutritional needs of the mother and baby
doi: 10.1073/pnas.74.8.3340
Why Plan Sponsors and Brokers Should Care About GLP-1s GLP-1s have been approved to treat diabetes and weight loss, and are showing promise in the treatment of other cardiometabolic diseases
It works by increasing brain active compounds or neurotransmitters, including norepinephrine, that affect hunger signals in the brain
The development of GLP-/GIP dual agonists provides a more complete scheme for the treatment of metabolic diseases, but the safety of more dual agonists or multiple agonists in clinical trials is also worthy of attention
Not everyone is a candidate for these weight loss medications, and they can have a range of side effects
